Schubert & Co’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50
Closed -$2.71K 489
2023
Q1
$2.71K Sell
50
-6
-11% -$349 ﹤0.01% 758
2022
Q4
$3.35K Buy
56
+1
+2% +$54 ﹤0.01% 598
2022
Q3
$2K Buy
55
+1
+2% +$50 ﹤0.01% 772
2022
Q2
$2K Buy
54
+34
+170% +$1.74K ﹤0.01% 748
2022
Q1
$1K Buy
20
+6
+43% +$313 ﹤0.01% 660
2021
Q4
$1K Buy
+14
New +$722 ﹤0.01% 611

Other funds holding EHC

Schubert & Co's EHC Position: Q2 2023 in Review

Schubert & Co sold out of Encompass Health (EHC) in Q2 2023, closing a stake of 50 shares — an estimated $2.71K sold.

Schubert & Co first reported a position in EHC in Q4 2021 and held it in 6 quarters. The position peaked at $3.35K in Q4 2022. 385 funds tracked by Wall St. Rank hold EHC as of Q2 2023.

  • Schubert & Co reported no remaining Encompass Health position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 50 Encompass Health shares in Q2 2023, an estimated $2.71K.
  • Schubert & Co first reported a position in Encompass Health in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Encompass Health position peaked at $3.35K in Q4 2022.
  • 385 funds tracked by Wall St. Rank held Encompass Health as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.